Kaijie provides molecular detection instruments to developing countries

Kaijie (NASDAQ: QGEN; Frankfurt, PriME Standard: QIA) has been selected by the United Nations to conduct international pilot projects to provide developing countries with portable and rapid molecular diagnostic instruments for infectious animal diseases.

Kay's ESE-Quant Tube SCanner is battery-powered, weighs only two pounds, and is only a desktop TV, making it easy to carry. In this project with the United Nations' FAO and the International Atomic Energy Agency (IAEA), Keigher's targeted detection instruments can isolate and analyze DNA and RNA from viruses in remote areas without sampling to the laboratory. Conduct tests to avoid the economic and time-consuming waste of transport samples. The rapid diagnosis at the scene helps to respond quickly to disease outbreaks at the source and control the further development of the epidemic.

Kaijie will initially provide 50 such instruments for health facilities in 35 developing countries in Africa, Asia and South America. The three-year plan will evaluate the diagnostic platform for the diagnosis of infectious animal diseases, including bird flu (H5N1), PPR, and CBPP. These animal diseases have caused huge economic losses and have fed millions of people with food supplies.

Kaijie will begin providing these molecular detection instruments in the second half of November 2010. According to project achievements, this plan may extend the detection of up to ten livestock diseases. This plan may also be implemented in other countries.

Kaijie has always been a leader in science and technology and is committed to the development of innovative targeted detection platforms for healthcare and applied testing such as veterinary research, food safety, environmental protection and biodefense. This instrument is the actual application of its advanced technology after Kaijie acquired ESE GmbH, which specializes in the production and development of portable molecular diagnostic instruments in January 2010. Due to the increasing use of molecular diagnostic technology, emergency rooms, emergency care, ambulance, and portable detection instruments and solutions that require fast results export, these technologies will also play an increasingly important role in human health care.

"As a global leader in sample preparation and analysis technologies, Kajal has always been at the forefront of applying advanced portable technologies to genetic testing, especially in some developing countries where targeted detection can be applied to healthcare and agricultural needs. Therefore, these technologies can make a great contribution to the improvement of social and economic conditions.This joint project of the UN Food and Agriculture Organization of the United Nations and the International Atomic Energy Agency (IAEA) on animal diseases and Kaijie initiated the careHPV campaign to combat cervical cancer in women in developing countries. It will help save more lives and allow more people to experience this detection technology.” Dr. Konrad Fau LStich, Director of Strategic Alliance at Kaijie stated, “The screening system we provide for this project will advance Qijie’s development strategy and improve The leading position in the field of sexual detection. We are very honored that our application testing technology can assist in the completion of this international program to help detect livestock infectious diseases."

"We believe that molecular veterinary diagnosis plays an increasingly important role in the early detection of highly contagious animal diseases," explains Dr. Hermann Unger, project manager for the project in Vienna. "In order to effectively implement this program, we must rely on low prices. , high-quality, portable and easy-to-use detection methods. Only by this means can we obtain information on possible disease outbreaks in the field and quickly implement monitoring measures for all UN member states. We are very grateful to the cooperation of Qi Jie Company and provide technology. And logistic support and developed a high-performance platform for our needs to control these devastating animal diseases."

The spread of cross-border animal diseases has caused great difficulties for developing countries and regions. For example, the outbreak of bird flu has not only caused devastating damage to millions of poultry in Asia, Africa and Europe, but also contagious to human health. A cattle epidemic in Botswana in 1995 caused economic losses of up to 500 million U.S. dollars. Worldwide, more than 1 billion sheep are at risk of contracting PPR, accounting for 60% of the total global population of small ruminants. This joint project of the UN Food and Agriculture Organization and the International Atomic Energy Agency aims to rapidly diagnose and effectively control the outbreak of this epidemic through the use of advanced detection technology from Kaijie.

Kaijie's innovative ESE-Quant Tube Scanner can be used anywhere. With one push of a button, the instrument can be based on the use of isothermal nucleic acid amplification technology to replicate and analyze viral DNA or RNA in a sample without the need for laboratory conditions. It maintains highly sensitive, real-time measurements while running, while providing quality control of the test results. This portable instrument can process up to 8 samples simultaneously in approximately 30 minutes, and analysis results can be imported directly into a desktop computer or notebook.

About Kejie Kejie is a Dutch holding company and is a global leader in sample preparation and inspection technology. Sample preparation techniques are used to separate and prepare DNA, RNA, and proteins from biological samples such as blood or tissues. Detection techniques are used to analyze these isolated biomolecules. The company's customers are located in molecular diagnostic laboratories, academic research institutions, pharmaceutical and biotechnology companies, and application testing customers. The products are used for forensic sample identification, animal or food inspection, and pharmaceutical process control. Kaijie's detection technologies include the world's most widely used molecular diagnostic platform, which includes the digene HPV test, which is considered to be the gold standard for the detection of cervical cancer—the high-risk human papilloma virus (HPV). "Standards" also includes a complete set of solutions for the detection and diagnosis of infectious diseases. Kaijie has more than 3,600 employees in more than 30 locations around the world.